Astrazeneca Pharma India's Stock Sees Decline in Line with Sector Performance

Astrazeneca Pharma India, a midcap pharmaceutical company, saw a decline of 6.42% in its stock price on August 8th, 2024. This drop was in line with the overall performance of the sector, as the company underperformed by 6.89%. The stock had also fallen after two consecutive days of gains, indicating a possible trend reversal. On the same day, Astrazeneca Pharma India's stock touched an intraday low of Rs 6665, a decrease of 6.52%. However, the stock is still performing well in the long term, with its moving averages higher than the 50-day, 100-day, and 200-day averages. It is worth noting that the stock is currently lower than the 5-day and 20-day moving averages. In comparison to the Sensex, Astrazeneca Pharma India's stock performance was -6.06% on the day, while the Sensex only saw a decline of 0.56%. Over the past month, the company's stock has also outperformed the Sensex, with a decrease of only 0.40% compared to the Sensex's decline of 1.17%. Overall, Astrazeneca Pharma India's stock has seen a decline in its performance on August 8th, 2024. However, the company's long-term performance remains strong, and it has outperformed the Sensex in both the short and long term. Investors may want to hold onto their stocks for now, as recommended by MarketsMOJO.